Dr Caroline Vipond
Dr Caroline Vipond is a Senior Scientist in the Meningococcal and Pneumococcal laboratory at NIBSC and is responsible for the release of meningococcal polysaccharide and protein-based vaccines.
Her primary research interests are on meningococcal protein-based vaccines, characterization of complex products with a focus on developing assays to effectively measure vaccine potency and safety with a view to using non-animal models.
In addition, Caroline oversees the panel of meningococcal reference material, including a panel of typing monoclonal antibodies, ELISA reagents and production of WHO international standards.
Caroline obtained her PhD from Imperial College London in 2010 in the field of outer membrane vesicle and degree in Molecular and Cellular Biology from the University of Bath in 1999.
Caroline is the chair of the Meningitis Now Charity’s Scientific and Medical Advisory Panel.
If you are interested in collaborating with Caroline on pneumococcal or meningococcal research projects please contact email@example.com
M. Valente Pinto, K. Davis, N. Andrews, D. Goldblatt, R. Borrow, J. Southern, I. K. Nordgren, C. Vipond, E. Plested, E. Miller and M. D. Snape; Vaccine; 2020
G. Whiting, C. Vipond, A. Facchetti, H. Chan and J. Wheeler; Vaccine; 2019
C. Vipond, J. Sutherland, K. Nordgren, G. Kemp, A. Heath, R. Care and L. Studholme; Vaccine; 2019
L. Studholme, J. Sutherland, T. Desai, J. Hockley, R. Care, I. K. Nordgren and C. Vipond; Vaccine; 2019
C. M. C. Rodrigues, H. Chan, C. Vipond, K. Jolley, O. B. Harrison, J. Wheeler, G. Whiting, I. M. Feavers and M. C. J. Maiden; Wellcome open research; 2018
P. Bryan, S. Seabroke, J. Wong, K. Donegan, E. Webb, C. Goldsmith, C. Vipond and I. Feavers; The Lancet Child & Adolescent Health; 2018
C. Vipond, C. J. Swann, T. W. Dougall, P. Rigsby, F. Gao, N. J. Beresford and B. Bolgiano; Biologicals; 2017
C. Vipond, L. Findlay, I. Feavers and R. Care; ALTEX; 2016
G. Norheim, H. Sanders, J. W. Mellesdal, I. Sundfor, H. Chan, C. Brehony, C. Vipond, C. Dold, R. Care, M. Saleem, M. C. Maiden, J. P. Derrick, I. Feavers and A. J. Pollard; PLoS One; 2015
C. Vipond, B. Mulloy, P. Rigsby, K. Burkin and B. Bolgiano; Biologicals; 2012
C. Vipond, R. Care and I. M. Feavers; Vaccine; 2012
H. Sanders, C. Brehony, M. C. Maiden, C. Vipond and I. M. Feavers; Microbiology; 2012
D. Yero, C. Vipond, Y. Climent, G. Sardinas, I. M. Feavers and R. Pajon; Microbiology; 2010
N. Tsolakos, K. Lie, K. Bolstad, S. Maslen, P. A. Kristiansen, E. A. Hoiby, A. Wallington, C. Vipond, M. Skehel, C. M. Tang, I. M. Feavers, E. Wedege and J. X. Wheeler; Vaccine; 2010
M. Finney, T. Vaughan, S. Taylor, M. J. Hudson, C. Pratt, W. J.X., C. Vipond, I. Feavers, C. Jones, J. Findlow, R. Borrow and A. Gorringe; Human Vaccines; 2008
J. Wheeler, C. Vipond and I. Feavers; Proteomics-Clinical Applications; 2007
C. Vipond, J. Suker, C. Jones, C. Tang, I. M. Feavers and J. X. Wheeler; Proteomics; 2006
C. Vipond, J. X. Wheeler, C. J. Jones, I. M. Feavers and J. Suker; Human Vaccines; 2005